Abstract
This is the first case of a patient taking aprepitant for a post-acute COVID-19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome.
Author supplied keywords
Cite
CITATION STYLE
APA
Reinoso-Arija, R., López-Ramírez, C., Jimenez-Ruiz, J. A., & López-Campos, J. L. (2021). Effectiveness of aprepitant in post-acute COVID19 syndrome. Clinical Case Reports, 9(9). https://doi.org/10.1002/ccr3.4646
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free